GSK Consent Decree Sets “Aggressive” 150-Day Timeline For GMP Conformity
This article was originally published in The Tan Sheet
GlaxoSmithKline's consent decree mandates that the company notify the agency within 150 days of the corrective measures it has taken or plans to take in addressing FDA's good manufacturing practice concerns
You may also be interested in...
GlaxoSmithKline appears to have negotiated a more favorable consent decree agreement with FDA compared to previous pharmaceutical companies facing similar action
The seizure of two of GlaxoSmithKline's major prescription drugs is an example of the increased seriousness FDA is placing on individual warning letters
Perrigo promotes in pricing, planning